Page 37 - Divi Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.

US stocks rise as focus turns to stimulus, corporate earnings Wall Street's main indexes gained on Thursday, as investors looked to corporate earnings and signs of progress on a pandemic-relief package after data suggested the labor market was stabilizing. The Dow Jones Industrial Average rose 265.2 points, or 0.86% to 30,989.11. The S&P 500 rose 23.92 points, or 0.61% to 3,854.07, while the Nasdaq Composite rose 74.95 points, or 0.55%, to 13,684.96. European shares strengthen on recovery hopes European shares rose on Thursday, extending a rally for the fourth straight day, as investors were ...

Want stellar returns? Consider Divis Lab, Sun Pharma and ICICI among largecaps and IGL and MGL among midcaps for your portfolio

Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls Premium (REUTERS) Ronojoy Mazumdar , Bloomberg Overall in absolute terms, analysts’ average 12-month target price for Divi’s stock has risen about ₹134 in the past four weeks Share Via Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020. In just about two weeks, at least four brokerages have raised their price targets on Divi’s Laboratories Ltd., one of the top producers of active pharmaceutical ingredients, with Jefferies India Pvt.’s estimate -- which ta...

Vaccine progress adds to growth opportunities for Dr Reddy’s Premium A vial of the Russian Sputnik V coronavirus vaccine is pictured in Belgrade, Serbia, January 6, 2021. REUTERS/Fedja Grulovic (REUTERS) The success of the vaccine can improve the company's prospects that has been witnessing strong growth momentum in key markets. While many manufacturers have lined up their vaccines, analysts say there will be sufficient demand to consume at least 100 million doses in India Share Via Read Full Story MUMBAI: With coronavirus vaccines in the spotlight, Dr Reddy’s Laboratories has remained i...